Cuba announces high effectiveness of its Soberana 2 vaccine against coronavirus

Source : 112 Ukraine

The authorities claim that they have a total number of five candidate vaccines in the pipeline
15:04, 9 July 2021

MFA of Cuba

Cuban biopharmaceutical corporation BioCubaFarma said that two doses of its Soberana 2 vaccine have proven to be 91.2% effective against Covid-19, as Reuters reports.

The announcement came from the producer of Abdala vaccine. In June it was found to have a 92.28% efficacy.

Both vaccines are “low” tech, meaning they use a traditional approach deploying a part of the virus’s spike protein which helps the virus enter and infect cells, to build up the immune system.

These vaccines are generally less expensive to develop and easier to store and transport as they do not require extremely low temperatures.

While the Cuban efficacy claims have not been peer reviewed, the results, if accurate, would catapult the U.S.-boycotted Caribbean island nation into the select group of the United States, Germany and Russia that produce vaccines with efficacy of more than 90% - namely, Novavax, Pfizer-BioNTech, Moderna and Sputnik V.

Related: Chief Sinovac vaccine researcher dies of Covid-19 in Indonesia

Cuba says it has a total of five candidate vaccines in the pipeline, with Abdala and Soberana 2 expected to be quickly authorized for emergency use by local regulators and sent up for approval to the World Health Organization.

As it was reported earlier, Cuba is facing its worst COVID-19 outbreak since the start of the pandemic following the arrival of more contagious variants, setting new records for daily coronavirus cases at over 3,500 this week.

Related: Pfizer, BioNTech to request third shot of their vaccines for combating new Covid strains



Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more